Stock INDEX INDEX PHARMACEUTICALS HOLDING AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials InDex Pharmaceuticals Holding AB

Equities

INDEX

SE0008966295

Pharmaceuticals

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:49 2024-04-26 am EDT 		5-day change 1st Jan Change
0.368 SEK +5.14% Intraday chart for InDex Pharmaceuticals Holding AB +11.85% +43.75%
Apr. 26 InDex Pharmaceuticals Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 05 Index Pharmaceuticals Holding AB Announces Board Resignations CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 516.7 410.2 926.9 450.1 136.4 196 -
Enterprise Value (EV) 1 390.4 410.2 499.7 108.4 -155.6 282.3 501.9
P/E ratio -4.89 x - -8.29 x -4.45 x -1.42 x -0.75 x -0.9 x
Yield - - - - - - -
Capitalization / Revenue 5,871,670,682 x 11,719,128,286 x - - 1,398,575 x - -
EV / Revenue 4,436,375,227 x 11,719,128,286 x - - -1,595,825 x - -
EV / EBITDA -4.5 x -7.3 x -4.92 x -1.06 x 1.47 x -1.1 x -2.29 x
EV / FCF -4,588,581 x - -3,992,534 x - 4,097,242 x - -
FCF Yield -0% - -0% - 0% - -
Price to Book - - 2.14 x 1.35 x 0.57 x -2.04 x -0.62 x
Nbr of stocks (in thousands) 88,781 88,781 532,688 532,688 532,688 532,688 -
Reference price 2 5.820 4.620 1.740 0.8450 0.2560 0.3680 0.3680
Announcement Date 2/20/20 2/25/21 2/23/22 2/23/23 2/21/24 - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net sales 0.088 0.035 - - 97.5 - -
EBITDA 1 -86.77 -56.16 -101.7 -102.2 -106.2 -257.4 -219.4
EBIT 1 -87.7 -57.35 -102.9 -103.2 -107.4 -258.4 -220.4
Operating Margin -99,659.09% -163,854.29% - - -110.11% - -
Earnings before Tax (EBT) 1 -87.77 - -103 -100.3 -95.26 -258.6 -220.6
Net income 1 -87.8 - -103 -100.3 -95.26 -258.6 -220.6
Net margin -99,772.73% - - - -97.7% - -
EPS 2 -1.190 - -0.2100 -0.1900 -0.1800 -0.4900 -0.4100
Free Cash Flow -85.08 - -125.2 - -37.98 - -
FCF margin -96,682.95% - - - -38.95% - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share 2 - - - - - - -
Announcement Date 2/20/20 2/25/21 2/23/22 2/23/23 2/21/24 - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q3
Net sales 1 -
EBITDA -
EBIT -
Operating Margin -
Earnings before Tax (EBT) -
Net income 1 -37.9
Net margin -
EPS 2 -0.0700
Dividend per Share -
Announcement Date 11/28/23
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net Debt 1 - - - - - 86.3 306
Net Cash position 1 126 - 427 342 292 - -
Leverage (Debt/EBITDA) - - - - - -0.3353 x -1.394 x
Free Cash Flow -85.1 - -125 - -38 - -
ROE (net income / shareholders' equity) -103% - -42.6% -26.1% -33.3% - -
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share 2 - - 0.8100 0.6300 0.4500 -0.1800 -0.5900
Cash Flow per Share - - - - - - -
Capex - - - - - - -
Capex / Sales - - - - - - -
Announcement Date 2/20/20 2/25/21 2/23/22 2/23/23 2/21/24 - -
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.368 SEK
Average target price
0.535 SEK
Spread / Average Target
+45.38%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
INDEX PHARMACEUTICALS HOLDING AB Stock InDex Pharmaceuticals Holding AB
+43.75% 17.88M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. INDEX Stock
  4. Financials InDex Pharmaceuticals Holding AB